Table 3 Association between elevated ALT, immune status, ART usage and hepatitis viral co-infection expressed as odds ratios with 95% confidence intervals
| Â | Â | Univeriate | Multivariate | ||
|---|---|---|---|---|---|
| Â | High ALT N(%) | OR | 95% CI | OR | 95% CI |
Immunosuppression | Â | Â | Â | Â | Â |
No evidence | Â | 1.0 | - | 1.0 | Â |
Moderate |  | 0.74 | 0.16–3.45(P = 0.69) | 0.61 | 0.12–2.96(P = 0.54) |
Severe |  | 2.68 | 0.79–9.52(P = 0.13) | 2.48 | 0.68–9.02(P = 0.94) |
ART | Â | Â | Â | Â | Â |
Not on ART | 3(7.1) | 1.0 | - | 1.0 | Â |
On ART | 12(9.6) | 1.38 | 0.37–5.15(P = 0.09 | 1.95 | 0.24–3.77(P = 0.94) |
HBsAg | Â | Â | Â | Â | Â |
No | 14(93.3) | 1.0 | - | Â | Â |
Yes | 1(6.7) | 10.79 | 0.74–8.81(p = 0.14) |  |  |
HCV | Â | Â | Â | Â | Â |
No | 11(73.3) | 1.0 | - | 0.1 | Â |
Yes | 4(26.7) | 2.55 | 1.02–10.65(P = 0.04) | 2.83 | 0.75–10.62(P0.12) |
Hepatitis B/C viral co-infection | Â | Â | Â | Â | Â |
No | 0(0.0) | 1.0 | Â | 1.0 | Â |
Yes | 5(20.0) | 3.25 |  | 3.99 | 1.12–14.19(P = 0.03) |